Ask Warren

Pangen Biotech

222110 · KOSDAQ · ₩222110 · 팬젠

₩4,640▲ ₩60 (1.31%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩13B₩15B₩7.3B₩6.5B₩7.9B
Cost of sales₩8.9B₩9.5B₩6.3B₩5.8B₩7.4B
Gross profit₩4.5B₩5.1B₩986M₩660M₩530M
Operating income₩1.5B₩1B−₩4.2B−₩4.6B−₩3.3B
Net income₩2.1B₩944M−₩4.5B−₩4.5B−₩3.3B
Net income to shareholders₩2.1B₩944M−₩4.5B−₩4.5B−₩3.3B

Balance sheet

20252024202320222021
Total assets₩33B₩31B₩21B₩21B₩43B
Current assets₩23B₩21B₩9.8B₩8.6B₩31B
Cash and equivalents₩3.8B₩1.4B₩45M₩892M₩8.9B
Total liabilities₩2.8B₩5.6B₩8.2B₩3.5B₩22B
Current liabilities₩2.7B₩2.9B₩5.7B₩1.1B₩20B
Borrowings₩962M₩816M₩2B₩0₩19B
Total equity₩30B₩25B₩13B₩17B₩21B
Shareholders' equity₩30B₩25B₩13B₩17B₩21B

Cash flow

20252024202320222021
Cash from operations₩190M₩3B−₩3.5B−₩3.5B−₩3.3B
Capital spending₩563M₩360M———
Free cash flow−₩373M₩2.6B−₩3.5B−₩3.5B−₩3.3B

Consolidated where available. Amounts in won.

Also known as: Pangen Biotech / 팬젠 / 222110 / KRX:222110

Source: KRX statistical information